Latest Insider Transactions at Schwab Charles Corp (SCHW)
This section provides a real-time view of insider transactions for Schwab Charles Corp (SCHW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SCHWAB CHARLES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SCHWAB CHARLES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Bona fide gift
|
Indirect |
320
-0.02%
|
-
|
|
Nov 25
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
2,300
-11.29%
|
$188,600
$82.01 P/Share
|
|
Nov 25
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
2,300
+5.86%
|
$101,200
$44.24 P/Share
|
|
Nov 22
2024
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
12,739
-17.73%
|
$1,031,859
$81.17 P/Share
|
|
Nov 18
2024
|
Christopher V Dodds Director |
SELL
Open market or private sale
|
Indirect |
9,284
-2.05%
|
$752,004
$81.43 P/Share
|
|
Nov 18
2024
|
Christopher V Dodds Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,284
+33.48%
|
$352,792
$38.31 P/Share
|
|
Nov 15
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.49%
|
$720,000
$80.03 P/Share
|
|
Nov 14
2024
|
Stephen A Ellis Director |
SELL
Bona fide gift
|
Indirect |
35,316
-31.74%
|
-
|
|
Nov 14
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
2,700
-13.0%
|
$218,700
$81.68 P/Share
|
|
Nov 14
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
2,700
+6.8%
|
$118,800
$44.24 P/Share
|
|
Nov 13
2024
|
Charles A. Ruffel Director |
SELL
Open market or private sale
|
Direct |
2,998
-18.17%
|
$233,844
$78.65 P/Share
|
|
Nov 11
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
2,500
-12.15%
|
$192,500
$77.02 P/Share
|
|
Nov 11
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+6.33%
|
$110,000
$44.24 P/Share
|
|
Nov 06
2024
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Bona fide gift
|
Indirect |
1,321
-2.11%
|
-
|
|
Oct 25
2024
|
Richard A Wurster President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,479
-4.49%
|
$460,009
$71.98 P/Share
|
|
Oct 21
2024
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
17,225
-0.03%
|
$1,205,750
$70.9 P/Share
|
|
Oct 17
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
29,800
-0.75%
|
$2,145,600
$72.19 P/Share
|
|
Oct 16
2024
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
62,345
-0.1%
|
$4,488,840
$72.52 P/Share
|
|
Oct 16
2024
|
Charles R. Schwab Co-Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
62,345
+100.0%
|
$1,745,660
$28.44 P/Share
|
|
Sep 17
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.49%
|
$576,000
$64.06 P/Share
|
|
Aug 16
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.48%
|
$585,000
$65.24 P/Share
|
|
Aug 15
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
12,320
-0.66%
|
$800,800
$65.11 P/Share
|
|
Aug 01
2024
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
1,150
-1.82%
|
$74,750
$65.2 P/Share
|
|
Jul 31
2024
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
67,386
-0.11%
|
$4,380,090
$65.11 P/Share
|
|
Jul 31
2024
|
Charles R. Schwab Co-Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
67,386
+100.0%
|
$1,819,422
$27.45 P/Share
|
|
Jul 19
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.24%
|
$558,000
$62.25 P/Share
|
|
Jul 17
2024
|
Richard A Wurster President |
BUY
Open market or private purchase
|
Direct |
10,000
+6.48%
|
$620,000
$62.05 P/Share
|
|
Jul 17
2024
|
Walter W Bettinger Co-Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
25,000
+2.93%
|
$1,650,000
$66.26 P/Share
|
|
Jul 11
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
780
-4.14%
|
$58,500
$75.0 P/Share
|
|
Jul 11
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
780
+2.07%
|
$34,320
$44.24 P/Share
|
|
Jul 01
2024
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Grant, award, or other acquisition
|
Direct |
11,191
+23.23%
|
-
|
|
Jun 20
2024
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
9,000
-0.48%
|
$648,000
$72.49 P/Share
|
|
Jun 12
2024
|
Bernard J. Clark MD Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
8,164
-6.29%
|
$612,300
$75.0 P/Share
|
|
Jun 12
2024
|
Bernard J. Clark MD Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
8,164
+100.0%
|
$424,528
$52.05 P/Share
|
|
May 28
2024
|
John K Adams Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+3.71%
|
-
|
|
May 28
2024
|
Charles A. Ruffel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+9.91%
|
-
|
|
May 28
2024
|
Todd M Ricketts Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+0.76%
|
-
|
|
May 28
2024
|
Bernard J. Clark MD Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
77,431
-19.87%
|
$5,497,601
$71.4 P/Share
|
|
May 28
2024
|
Bernard J. Clark MD Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
28,670
+100.0%
|
$1,204,140
$42.99 P/Share
|
|
May 28
2024
|
Gerri Martin Flickinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+29.59%
|
-
|
|
May 28
2024
|
Paula A Sneed Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+21.48%
|
-
|
|
May 28
2024
|
Carolyn Schwab Pomerantz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+18.14%
|
-
|
|
May 28
2024
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+16.43%
|
-
|
|
May 28
2024
|
Bharat Masrani Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+19.91%
|
-
|
|
May 28
2024
|
Brian M Levitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+19.91%
|
-
|
|
May 28
2024
|
Frank C Herringer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+16.43%
|
-
|
|
May 28
2024
|
Marianne Catherine Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+11.24%
|
-
|
|
May 28
2024
|
Stephen A Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+16.43%
|
-
|
|
May 28
2024
|
Joan Dea Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+6.34%
|
-
|
|
May 28
2024
|
Christopher V Dodds Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,809
+16.43%
|
-
|